Open access · CC-BY
via OpenAlex
Deciphering the roadmap of in vivo reprogramming toward pluripotency
Dafni Chondronasiou, Jaime Martínez de Villarreal, Elena Melendez, Cian J. Lynch, Natalia del Pozo, Marta Kovatcheva, Mònica Aguilera, Neus Prats, Francisco X. Real, Manuel Serrano
Stem Cell Reports · 2022 · ▲ 39 citations
Abstract
Differentiated cells can be converted into pluripotent stem cells by expressing the transcription factors OCT4, SOX2, KLF4, and MYC (OSKM) in a process known as reprogramming. Here, using single-cell RNA sequencing of pancreas undergoing reprogramming, we identify markers along the trajectory from acinar cell identity to pluripotency. These markers allow direct in situ visualization of cells undergoing dedifferentiation and acquiring features of early and advanced intermediate reprogramming. We also find that a fraction of cells do not dedifferentiate upon OSKM expression and are characterized by stress markers of the REG3 and AP-1 families. Importantly, most markers of intermediate reprogramming in the pancreas are also observed in stomach, colon, and cultured fibroblasts expressing OSKM. Among them is LY6A, a protein characteristic of progenitor cells and generally upregulated during tissue repair. Our roadmap defines intermediate reprogramming states that could be functionally relevant for tissue regeneration and rejuvenation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.stemcr.2022.09.009
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Chondronasiou, D., Villarreal, J.M.D., Melendez, E., Lynch, C.J., Pozo, N.D., Kovatcheva, M., Aguilera, M., Prats, N., Real, F.X., & Serrano, M. (2022). Deciphering the roadmap of in vivo reprogramming toward pluripotency. <em>Stem Cell Reports</em>. https://doi.org/10.1016/j.stemcr.2022.09.009
Vancouver
Chondronasiou D, Villarreal JMD, Melendez E, Lynch CJ, Pozo ND, Kovatcheva M, et al. Deciphering the roadmap of in vivo reprogramming toward pluripotency. Stem Cell Reports. 2022. doi:10.1016/j.stemcr.2022.09.009.
BibTeX
@article{dafni2022Deciph,
title = {Deciphering the roadmap of in vivo reprogramming toward pluripotency},
author = {Dafni Chondronasiou and Jaime Martínez de Villarreal and Elena Melendez and Cian J. Lynch and Natalia del Pozo and Marta Kovatcheva and Mònica Aguilera and Neus Prats and Francisco X. Real and Manuel Serrano},
journal = {Stem Cell Reports},
year = {2022},
doi = {10.1016/j.stemcr.2022.09.009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2022
Open access · CC-BY
Multi‐omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming
Nature Communications 2021
Open access · CC-BY
In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche
Science Advances 2022
Open access · CC-BY
Intermediate cells of in vitro cellular reprogramming and in vivo tissue regeneration require desmoplakin
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · OA
Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming
Current Stem Cell Research & Therapy 2025
Citation only
Can iPSCs Turn Back Time? Prospects and Pitfalls in Age Reversal
Current stem cell research & therapy 2026
Citation only